A Comparative Study to Evaluate the Effect of Kantakari Ghrita and Dadimadi Ghrita in Children with Dry Cough.

Comparative clinical trial to evaluate the efficacy of kantakari ghrita and dadimadi ghrita in the management of vataja kasa in childrens. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/05/110514

Enrollment

Registered

2026-05-12

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R05- Cough

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1)Children aged 5 to 12 years of age. 2)Clinically diagnosed cases of Vataja Kasa as per Ayurvedic signs and symptoms. 3)Both female and male sex. 4)Willingness of parents/guardians to provide informed consent.

Exclusion criteria

Exclusion criteria: 1)Age below 5 years and above 12 years were excluded Children diagnosed with non-Vataja types of Kasa, such as Kaphaja, Pittaja, Kshayaja Kasa. 2)Children with acute or chronic systemic diseases, including heart disease, renal disease, epilepsy, or congenital anomalies. 3)Ongoing participation in another clinical trial.

Design outcomes

Primary

Measure	Time frame
To assess and compare the improvement in the clinical signs and symptoms of Vataja Kasa in children treated with Kantakari Ghrita and Dadimadi Ghrita, based on subjective assessment parameters including Kasa Vega (frequency of cough), Vega Pariksha (duration/intensity of cough bouts), Ura Shoola (chest pain), Shirashoola (headache), Sushka Mukha-Gala (dryness of mouth and throat), and Swarabheda (hoarseness of voice) before and after treatment.Timepoint: 7 days	—

Measure

Time frame

To assess and compare the improvement in the clinical signs and symptoms of Vataja Kasa in children treated with Kantakari Ghrita and Dadimadi Ghrita, based on subjective assessment parameters including Kasa Vega (frequency of cough), Vega Pariksha (duration/intensity of cough bouts), Ura Shoola (chest pain), Shirashoola (headache), Sushka Mukha-Gala (dryness of mouth and throat), and Swarabheda (hoarseness of voice) before and after treatment.Timepoint: 7 days

—

Secondary

Measure	Time frame
1)To evaluate the individual therapeutic efficacy of Kantakari Ghrita in the management of Vataja Kasa in children. 2)To evaluate the individual therapeutic efficacy of Dadimadi Ghrita in the management of Vataja Kasa in children. 3)To compare the percentage of symptomatic relief produced by both interventions during the study period. 4)To assess the safety and tolerability of both Ghrita formulations in children during the treatment period.Timepoint: 7 days	—

Measure

Time frame

1)To evaluate the individual therapeutic efficacy of Kantakari Ghrita in the management of Vataja Kasa in children. 2)To evaluate the individual therapeutic efficacy of Dadimadi Ghrita in the management of Vataja Kasa in children. 3)To compare the percentage of symptomatic relief produced by both interventions during the study period. 4)To assess the safety and tolerability of both Ghrita formulations in children during the treatment period.Timepoint: 7 days

—

Countries

India

Contacts

Public ContactDr Anand Gurav

Late Kedari Redekar Ayurvedic Mahavidyalay,Gadhinglaj

Rasaihospital@gmail.com9822187049

Outcome results